The role of surgical management in primary small bowel lymphoma: A single-center experience

Information on primary small intestinal lymphoma is more limited than for gastric lymphoma because most of the previous studies did not focus on the former. Few prognostic indicators in primary intestinal lymphoma have been reliably established because of limited patient numbers and variations in cr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2017-10, Vol.43 (10), p.1886-1893
Hauptverfasser: Hong, Y.-W., Kuo, I.-M., Liu, Y.-Y., Yeh, T.-S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1893
container_issue 10
container_start_page 1886
container_title European journal of surgical oncology
container_volume 43
creator Hong, Y.-W.
Kuo, I.-M.
Liu, Y.-Y.
Yeh, T.-S.
description Information on primary small intestinal lymphoma is more limited than for gastric lymphoma because most of the previous studies did not focus on the former. Few prognostic indicators in primary intestinal lymphoma have been reliably established because of limited patient numbers and variations in criteria for patient selection. In this study, we retrospectively reviewed the clinical and pathological characteristics of small intestinal lymphoma cases from our hospital, to determine prognostic factors and to clarify the effect of surgical resection on prognosis. Eighty-two patients were enrolled in this retrospective study between January 1997 and December 2012. Patients were divided into two groups based on whether or not they underwent surgical management. Gross resection was defined as complete removal of the primary lesion(s), as confirmed by the naked eye. Combined therapy refers to concurrent surgery and chemotherapy. The clinicopathological characteristics and long-term outcomes of patients were analyzed and compared between the two groups. Most of the patients had abdominal pain (75.6%), and some had loss of body weight (29.3%) and bowel perforation (22.0%). Sixty-two patients (75.6%) underwent surgical management. Patients in the surgery group presented with fewer B symptoms (fever, night sweats, and weight loss; P = 0.035) but more bulky disease (P = 0.009). The ileocecal region was the most common site of solitary involvement (34.1%). The most common reason for surgery was for tumor-related complications (61.3%). Seven patients (11.3%) developed major complications of surgery, but these were not related to the indication, timing, or type of surgery. Only major surgical complications were statistically significant in relation to early mortality (P = 0.004). The estimated 5-year progression-free survival (PFS) was 35.1% and 5-year overall survival (OS) was 43.2%. Univariate analysis revealed that patients in the surgery group had improved 5-year PFS (P = 0.028). T-cell lymphoma, involvement of multiple gastrointestinal regions and extranodal involvement, higher scores for International Prognostic Index (IPI), more advanced Ann Arbor stage, lactate dehydrogenase (LDH) levels above 215 U/L, and management without combined therapy were prognostic for shorter PFS and OS in univariate analyses. Individuals who received R0 resection or gross resection had improved 5-year PFS and OS. Cox regression analysis demonstrated that primary T-cell lymphoma was an
doi_str_mv 10.1016/j.ejso.2017.06.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1924594869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798317305772</els_id><sourcerecordid>1924594869</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-5aaf467837befda05e94f9e4b193edf0f6e5cda6129aa5e20d66643e399d02523</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EouXxBxiQR5YE24ntGLFUiJdUiaVMDJbr3LSunLjYLdB_T0oLI9OVjr5zpPshdEFJTgkV14scFinkjFCZE5H30QEaUl6wjFEuD9GQyLLKpKqKATpJaUEIUYVUx2jAKskp4XKI3iZzwDF4wKHBaR1nzhqPW9OZGbTQrbDr8DK61sQNTq3xHk_DJ3jsN-1yHlpzg0c4uW7mIbM9DhHD1xKig87CGTpqjE9wvr-n6PXhfnL3lI1fHp_vRuPMloytMm5MUwpZFXIKTW0IB1U2CsopVQXUDWkEcFsbQZkyhgMjtRCiLKBQqiaMs-IUXe12lzG8ryGtdOuSBe9NB2GdNFWs5KqshOpRtkNtDClFaPT-OU2J3krVC72VqrdSNRG6j_rS5X5_PW2h_qv8WuyB2x0A_ZcfDqJO9sdA7SLYla6D-2__G755iU8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1924594869</pqid></control><display><type>article</type><title>The role of surgical management in primary small bowel lymphoma: A single-center experience</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hong, Y.-W. ; Kuo, I.-M. ; Liu, Y.-Y. ; Yeh, T.-S.</creator><creatorcontrib>Hong, Y.-W. ; Kuo, I.-M. ; Liu, Y.-Y. ; Yeh, T.-S.</creatorcontrib><description>Information on primary small intestinal lymphoma is more limited than for gastric lymphoma because most of the previous studies did not focus on the former. Few prognostic indicators in primary intestinal lymphoma have been reliably established because of limited patient numbers and variations in criteria for patient selection. In this study, we retrospectively reviewed the clinical and pathological characteristics of small intestinal lymphoma cases from our hospital, to determine prognostic factors and to clarify the effect of surgical resection on prognosis. Eighty-two patients were enrolled in this retrospective study between January 1997 and December 2012. Patients were divided into two groups based on whether or not they underwent surgical management. Gross resection was defined as complete removal of the primary lesion(s), as confirmed by the naked eye. Combined therapy refers to concurrent surgery and chemotherapy. The clinicopathological characteristics and long-term outcomes of patients were analyzed and compared between the two groups. Most of the patients had abdominal pain (75.6%), and some had loss of body weight (29.3%) and bowel perforation (22.0%). Sixty-two patients (75.6%) underwent surgical management. Patients in the surgery group presented with fewer B symptoms (fever, night sweats, and weight loss; P = 0.035) but more bulky disease (P = 0.009). The ileocecal region was the most common site of solitary involvement (34.1%). The most common reason for surgery was for tumor-related complications (61.3%). Seven patients (11.3%) developed major complications of surgery, but these were not related to the indication, timing, or type of surgery. Only major surgical complications were statistically significant in relation to early mortality (P = 0.004). The estimated 5-year progression-free survival (PFS) was 35.1% and 5-year overall survival (OS) was 43.2%. Univariate analysis revealed that patients in the surgery group had improved 5-year PFS (P = 0.028). T-cell lymphoma, involvement of multiple gastrointestinal regions and extranodal involvement, higher scores for International Prognostic Index (IPI), more advanced Ann Arbor stage, lactate dehydrogenase (LDH) levels above 215 U/L, and management without combined therapy were prognostic for shorter PFS and OS in univariate analyses. Individuals who received R0 resection or gross resection had improved 5-year PFS and OS. Cox regression analysis demonstrated that primary T-cell lymphoma was an independent negative prognostic factor for both OS and PFS. Combined therapy is an independent prognostic factor for long-term survival in small intestinal lymphoma. Gross resection is recommended in patients with small intestinal lymphoma and leads to improved PFS without significantly increasing the risk of complications. Emergency surgery does not lead to poor prognosis. However, caution is warranted in the management of all patients, because of the high risk of post-operative complications and potential for early mortality.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2017.06.016</identifier><identifier>PMID: 28751057</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Combined therapy ; Digestive System Surgical Procedures - methods ; Disease-Free Survival ; Emergency operation ; Female ; Follow-Up Studies ; Humans ; Intestinal Neoplasms - diagnosis ; Intestinal Neoplasms - mortality ; Intestinal Neoplasms - surgery ; Intestine, Small ; Lymphoma, T-Cell - diagnosis ; Lymphoma, T-Cell - mortality ; Lymphoma, T-Cell - surgery ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Small intestinal lymphoma ; Surgery ; Survival Rate - trends ; Taiwan - epidemiology ; Time Factors ; Young Adult</subject><ispartof>European journal of surgical oncology, 2017-10, Vol.43 (10), p.1886-1893</ispartof><rights>2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology</rights><rights>Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-5aaf467837befda05e94f9e4b193edf0f6e5cda6129aa5e20d66643e399d02523</citedby><cites>FETCH-LOGICAL-c422t-5aaf467837befda05e94f9e4b193edf0f6e5cda6129aa5e20d66643e399d02523</cites><orcidid>0000-0002-9993-7498</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejso.2017.06.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28751057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hong, Y.-W.</creatorcontrib><creatorcontrib>Kuo, I.-M.</creatorcontrib><creatorcontrib>Liu, Y.-Y.</creatorcontrib><creatorcontrib>Yeh, T.-S.</creatorcontrib><title>The role of surgical management in primary small bowel lymphoma: A single-center experience</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Information on primary small intestinal lymphoma is more limited than for gastric lymphoma because most of the previous studies did not focus on the former. Few prognostic indicators in primary intestinal lymphoma have been reliably established because of limited patient numbers and variations in criteria for patient selection. In this study, we retrospectively reviewed the clinical and pathological characteristics of small intestinal lymphoma cases from our hospital, to determine prognostic factors and to clarify the effect of surgical resection on prognosis. Eighty-two patients were enrolled in this retrospective study between January 1997 and December 2012. Patients were divided into two groups based on whether or not they underwent surgical management. Gross resection was defined as complete removal of the primary lesion(s), as confirmed by the naked eye. Combined therapy refers to concurrent surgery and chemotherapy. The clinicopathological characteristics and long-term outcomes of patients were analyzed and compared between the two groups. Most of the patients had abdominal pain (75.6%), and some had loss of body weight (29.3%) and bowel perforation (22.0%). Sixty-two patients (75.6%) underwent surgical management. Patients in the surgery group presented with fewer B symptoms (fever, night sweats, and weight loss; P = 0.035) but more bulky disease (P = 0.009). The ileocecal region was the most common site of solitary involvement (34.1%). The most common reason for surgery was for tumor-related complications (61.3%). Seven patients (11.3%) developed major complications of surgery, but these were not related to the indication, timing, or type of surgery. Only major surgical complications were statistically significant in relation to early mortality (P = 0.004). The estimated 5-year progression-free survival (PFS) was 35.1% and 5-year overall survival (OS) was 43.2%. Univariate analysis revealed that patients in the surgery group had improved 5-year PFS (P = 0.028). T-cell lymphoma, involvement of multiple gastrointestinal regions and extranodal involvement, higher scores for International Prognostic Index (IPI), more advanced Ann Arbor stage, lactate dehydrogenase (LDH) levels above 215 U/L, and management without combined therapy were prognostic for shorter PFS and OS in univariate analyses. Individuals who received R0 resection or gross resection had improved 5-year PFS and OS. Cox regression analysis demonstrated that primary T-cell lymphoma was an independent negative prognostic factor for both OS and PFS. Combined therapy is an independent prognostic factor for long-term survival in small intestinal lymphoma. Gross resection is recommended in patients with small intestinal lymphoma and leads to improved PFS without significantly increasing the risk of complications. Emergency surgery does not lead to poor prognosis. However, caution is warranted in the management of all patients, because of the high risk of post-operative complications and potential for early mortality.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Combined therapy</subject><subject>Digestive System Surgical Procedures - methods</subject><subject>Disease-Free Survival</subject><subject>Emergency operation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Intestinal Neoplasms - diagnosis</subject><subject>Intestinal Neoplasms - mortality</subject><subject>Intestinal Neoplasms - surgery</subject><subject>Intestine, Small</subject><subject>Lymphoma, T-Cell - diagnosis</subject><subject>Lymphoma, T-Cell - mortality</subject><subject>Lymphoma, T-Cell - surgery</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Small intestinal lymphoma</subject><subject>Surgery</subject><subject>Survival Rate - trends</subject><subject>Taiwan - epidemiology</subject><subject>Time Factors</subject><subject>Young Adult</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtPwzAUhS0EouXxBxiQR5YE24ntGLFUiJdUiaVMDJbr3LSunLjYLdB_T0oLI9OVjr5zpPshdEFJTgkV14scFinkjFCZE5H30QEaUl6wjFEuD9GQyLLKpKqKATpJaUEIUYVUx2jAKskp4XKI3iZzwDF4wKHBaR1nzhqPW9OZGbTQrbDr8DK61sQNTq3xHk_DJ3jsN-1yHlpzg0c4uW7mIbM9DhHD1xKig87CGTpqjE9wvr-n6PXhfnL3lI1fHp_vRuPMloytMm5MUwpZFXIKTW0IB1U2CsopVQXUDWkEcFsbQZkyhgMjtRCiLKBQqiaMs-IUXe12lzG8ryGtdOuSBe9NB2GdNFWs5KqshOpRtkNtDClFaPT-OU2J3krVC72VqrdSNRG6j_rS5X5_PW2h_qv8WuyB2x0A_ZcfDqJO9sdA7SLYla6D-2__G755iU8</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Hong, Y.-W.</creator><creator>Kuo, I.-M.</creator><creator>Liu, Y.-Y.</creator><creator>Yeh, T.-S.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9993-7498</orcidid></search><sort><creationdate>201710</creationdate><title>The role of surgical management in primary small bowel lymphoma: A single-center experience</title><author>Hong, Y.-W. ; Kuo, I.-M. ; Liu, Y.-Y. ; Yeh, T.-S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-5aaf467837befda05e94f9e4b193edf0f6e5cda6129aa5e20d66643e399d02523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Combined therapy</topic><topic>Digestive System Surgical Procedures - methods</topic><topic>Disease-Free Survival</topic><topic>Emergency operation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Intestinal Neoplasms - diagnosis</topic><topic>Intestinal Neoplasms - mortality</topic><topic>Intestinal Neoplasms - surgery</topic><topic>Intestine, Small</topic><topic>Lymphoma, T-Cell - diagnosis</topic><topic>Lymphoma, T-Cell - mortality</topic><topic>Lymphoma, T-Cell - surgery</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Small intestinal lymphoma</topic><topic>Surgery</topic><topic>Survival Rate - trends</topic><topic>Taiwan - epidemiology</topic><topic>Time Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hong, Y.-W.</creatorcontrib><creatorcontrib>Kuo, I.-M.</creatorcontrib><creatorcontrib>Liu, Y.-Y.</creatorcontrib><creatorcontrib>Yeh, T.-S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hong, Y.-W.</au><au>Kuo, I.-M.</au><au>Liu, Y.-Y.</au><au>Yeh, T.-S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of surgical management in primary small bowel lymphoma: A single-center experience</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2017-10</date><risdate>2017</risdate><volume>43</volume><issue>10</issue><spage>1886</spage><epage>1893</epage><pages>1886-1893</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Information on primary small intestinal lymphoma is more limited than for gastric lymphoma because most of the previous studies did not focus on the former. Few prognostic indicators in primary intestinal lymphoma have been reliably established because of limited patient numbers and variations in criteria for patient selection. In this study, we retrospectively reviewed the clinical and pathological characteristics of small intestinal lymphoma cases from our hospital, to determine prognostic factors and to clarify the effect of surgical resection on prognosis. Eighty-two patients were enrolled in this retrospective study between January 1997 and December 2012. Patients were divided into two groups based on whether or not they underwent surgical management. Gross resection was defined as complete removal of the primary lesion(s), as confirmed by the naked eye. Combined therapy refers to concurrent surgery and chemotherapy. The clinicopathological characteristics and long-term outcomes of patients were analyzed and compared between the two groups. Most of the patients had abdominal pain (75.6%), and some had loss of body weight (29.3%) and bowel perforation (22.0%). Sixty-two patients (75.6%) underwent surgical management. Patients in the surgery group presented with fewer B symptoms (fever, night sweats, and weight loss; P = 0.035) but more bulky disease (P = 0.009). The ileocecal region was the most common site of solitary involvement (34.1%). The most common reason for surgery was for tumor-related complications (61.3%). Seven patients (11.3%) developed major complications of surgery, but these were not related to the indication, timing, or type of surgery. Only major surgical complications were statistically significant in relation to early mortality (P = 0.004). The estimated 5-year progression-free survival (PFS) was 35.1% and 5-year overall survival (OS) was 43.2%. Univariate analysis revealed that patients in the surgery group had improved 5-year PFS (P = 0.028). T-cell lymphoma, involvement of multiple gastrointestinal regions and extranodal involvement, higher scores for International Prognostic Index (IPI), more advanced Ann Arbor stage, lactate dehydrogenase (LDH) levels above 215 U/L, and management without combined therapy were prognostic for shorter PFS and OS in univariate analyses. Individuals who received R0 resection or gross resection had improved 5-year PFS and OS. Cox regression analysis demonstrated that primary T-cell lymphoma was an independent negative prognostic factor for both OS and PFS. Combined therapy is an independent prognostic factor for long-term survival in small intestinal lymphoma. Gross resection is recommended in patients with small intestinal lymphoma and leads to improved PFS without significantly increasing the risk of complications. Emergency surgery does not lead to poor prognosis. However, caution is warranted in the management of all patients, because of the high risk of post-operative complications and potential for early mortality.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28751057</pmid><doi>10.1016/j.ejso.2017.06.016</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9993-7498</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2017-10, Vol.43 (10), p.1886-1893
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_1924594869
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Aged
Aged, 80 and over
Combined therapy
Digestive System Surgical Procedures - methods
Disease-Free Survival
Emergency operation
Female
Follow-Up Studies
Humans
Intestinal Neoplasms - diagnosis
Intestinal Neoplasms - mortality
Intestinal Neoplasms - surgery
Intestine, Small
Lymphoma, T-Cell - diagnosis
Lymphoma, T-Cell - mortality
Lymphoma, T-Cell - surgery
Male
Middle Aged
Prognosis
Retrospective Studies
Small intestinal lymphoma
Surgery
Survival Rate - trends
Taiwan - epidemiology
Time Factors
Young Adult
title The role of surgical management in primary small bowel lymphoma: A single-center experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T01%3A50%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20surgical%20management%20in%20primary%20small%20bowel%20lymphoma:%20A%20single-center%20experience&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Hong,%20Y.-W.&rft.date=2017-10&rft.volume=43&rft.issue=10&rft.spage=1886&rft.epage=1893&rft.pages=1886-1893&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2017.06.016&rft_dat=%3Cproquest_cross%3E1924594869%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1924594869&rft_id=info:pmid/28751057&rft_els_id=S0748798317305772&rfr_iscdi=true